Preliminary experience with steroidal ovarian suppression for prevention of severe ovarian hyperstimulation syndrome in IVF patients

Human Fertility

Volumn 4, Issue 4, 2001, Pages 246-248

  Rjosk, Hanns Kristian ^a   Abendstein, Burghard J ^b   Kreuzer, Edmund ^a   Schwärzler, Peter ^b  

^a Gemeinschaftspraxis Rjosk/Rommler   (Germany)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; GRAVIBINAN; HUMAN MENOPAUSAL GONADOTROPIN; HYDROXYPROGESTERONE CAPROATE; PROGESTERONE; STEROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HIGH RISK POPULATION; HUMAN; LUTEAL PHASE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL;

EID: 0035178092     PISSN: 14647273     EISSN: None     Source Type: Journal    
DOI: 10.1080/1464727012000199601     Document Type: Article

References (6)

1. Peripheral arterial vasodilation hypothesis: A new insight into the pathogenesis of ovarian hyperstimulation syndrome
2. Early and late presentation of the ovarian hyperstimulation syndrome: Two distinct entities with different risk factors
3. Ovarian hyperstimulation syndrome: An update review
4. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins
5. Luteal phase support and severe ovarian hyperstimulation syndrome
6. Distinction between early and late ovarian hyperstimulation syndrome